Modular Medical, Inc.(MODD)

Medical - Devices · San Diego, CA

$2.55+0.25 (+10.87%)

Delayed quote: Oct 6, 2026, 10:48 AM EDT

EV/Sales Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/Sales ratio is N/A as of 2026-10-06T14:53:06.795Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:53:06.795Z.

Quote observation: 2026-10-06T14:48:17.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 20,784,599
Total debt · period ending 2026-06-30: 278,000
Cash · period ending 2026-06-30: 3,920,000
TTM revenue · period ending 2026-06-30: 0

FMP input reference: 85842aa9b6cc8ebfa961f669867d571d507c26eab2d350d24b64fb3509ac0979

EV/EBITDA|P/S Ratio|Revenue|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

MODD EV/Sales Ratio Metrics

EV/SALES RATIO

N/A

MODD Competitors' EV/Sales Ratio

MODD

Modular Medical, Inc.

Current

Market Cap

$20.78M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACTU

Actuate Therapeutics Inc

vs MODD

Market Cap

$19.84M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LONA

LeonaBio, Inc.

vs MODD

Market Cap

$21.83M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AYTU

Aytu BioPharma, Inc.

vs MODD

Market Cap

$22.43M

EV/Sales Ratio

0.25x

TTM Avg

0.37x

3Y Avg

0.25x

5Y Avg

0.21x

NEUP

Neuphoria Therapeutics Inc.

vs MODD

Market Cap

$18.86M

EV/Sales Ratio

N/A

TTM Avg

13.65x

3Y Avg

401.05x

5Y Avg

54100.66x

ESLA

Estrella Immunopharma, Inc.

vs MODD

Market Cap

$18.78M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NXTC

NextCure, Inc.

vs MODD

Market Cap

$18.44M

EV/Sales Ratio

N/A

TTM Avg

15.07x

3Y Avg

94.54x

5Y Avg

94.54x

COSM

Cosmos Health Inc.

vs MODD

Market Cap

$18.30M

EV/Sales Ratio

0.44x

TTM Avg

0.52x

3Y Avg

0.46x

5Y Avg

0.60x

KYNB

Kyntra Bio, Inc.

vs MODD

Market Cap

$24.29M

EV/Sales Ratio

N/A

TTM Avg

1.44x

3Y Avg

1.04x

5Y Avg

4.23x

LPCN

Lipocine Inc.

vs MODD

Market Cap

$17.15M

EV/Sales Ratio

7.75x

TTM Avg

7.07x

3Y Avg

11.18x

5Y Avg

149.23x

NAME	MARKET CAP	EV/SALES RATIO	TTM	3Y	5Y
Modular Medical, Inc. (MODD)	$20.78M	N/A	N/A	N/A	N/A
Actuate Therapeutics Inc (ACTU)vs ›	$19.84M	N/A	N/A	N/A	N/A
LeonaBio, Inc. (LONA)vs ›	$21.83M	N/A	N/A	N/A	N/A
Aytu BioPharma, Inc. (AYTU)vs ›	$22.43M	0.25x	0.37x	0.25x	0.21x
Neuphoria Therapeutics Inc. (NEUP)vs ›	$18.86M	N/A	13.65x	401.05x	54100.66x
Estrella Immunopharma, Inc. (ESLA)vs ›	$18.78M	N/A	N/A	N/A	N/A
NextCure, Inc. (NXTC)vs ›	$18.44M	N/A	15.07x	94.54x	94.54x
Cosmos Health Inc. (COSM)vs ›	$18.30M	0.44x	0.52x	0.46x	0.60x
Kyntra Bio, Inc. (KYNB)vs ›	$24.29M	N/A	1.44x	1.04x	4.23x
Lipocine Inc. (LPCN)vs ›	$17.15M	7.75x	7.07x	11.18x	149.23x

Understanding EV/Sales

Enterprise Value (EV) = Market Cap + Total Debt - Cash

Sales = Total Revenue (TTM)

EV/Sales is commonly used because:

It works for unprofitable companies where P/E doesn't apply
Revenue is harder to manipulate than earnings
It supports comparisons across companies at different profitability stages
It is frequently used for software and other revenue-growth-focused companies

Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.

EV/Sales Ratio Formula & Definition

EV/Sales = Enterprise Value / Revenue (TTM)

Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/EBITDA P/S Ratio Revenue All Metrics